Achieve Life Sciences Stock (NASDAQ: ACHV) stock price, news, charts, stock research, profile.
You can purchase shares of Achieve Life Sciences (NASDAQ:ACHV) through any online brokerage.
Other companies in Achieve Life Sciences’s space includes: Invizyne Technologies (NASDAQ:IZTC), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Atossa Therapeutics (NASDAQ:ATOS).
Achieve Life Sciences has a consensus price target of $13.67.
The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $4.29 last updated November 22, 2024 at 4:01 PM EST.
There are no upcoming dividends for Achieve Life Sciences.
Achieve Life Sciences’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Achieve Life Sciences.
Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.